1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ponesimod
Trade Name:
Ponvory
Manufacturer/Distributor:
Janssen Inc.
Classification:
Sphingosine 1-phosphate receptor modulator
ATC Class:
L04AA - selective immunosuppresants
Status:
active
Notice of Compliance (yyyy/mm/dd):
2021/04/28
Date Marketed in Canada (yyyy/mm/dd):
2021/04/28
Presentation:
Tablets, induction packet: (2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg). DIN: 02515474
Tablet, maintenance packet: 20 mg. DIN: 02515482
Comments:
For treatment of adult patients with relapsing remitting multiple sclerosis. Initial titration done over 14 days (2 days each of varying doses) with maintenance dose of 20 mg daily thereafter.
Back to:
Drug Product Listings 
